Clene Inc. (CLNN)
NASDAQ: CLNN · Real-Time Price · USD
3.670
+0.080 (2.23%)
Jul 14, 2025, 4:00 PM - Market closed
Clene Revenue
Clene had revenue of $81.00K in the quarter ending March 31, 2025, with 10.96% growth. This brings the company's revenue in the last twelve months to $350.00K, down -43.55% year-over-year. In the year 2024, Clene had annual revenue of $342.00K, down -47.71%.
Revenue (ttm)
$350.00K
Revenue Growth
-43.55%
P/S Ratio
77.49
Revenue / Employee
$4,605
Employees
76
Market Cap
32.97M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Walmart | 685.09B |
Costco Wholesale | 268.78B |
PepsiCo | 91.52B |
The Procter & Gamble Company | 83.93B |
Unilever | 62.91B |
Anheuser-Busch InBev | 58.85B |
The Coca-Cola Company | 46.89B |
Philip Morris International | 38.39B |
CLNN News
- 14 days ago - Clene Provides Regulatory Update Following Constructive FDA Type-C Meeting on Neurofilament Biomarker Analysis Plan and Confirms Two Additional FDA Meetings - GlobeNewsWire
- 5 weeks ago - Clene Inc. Chief Executive Officer Rob Etherington to Present at the Investor Summit Virtual on June 10, 2025 - Accesswire
- 2 months ago - Clene Reports First Quarter 2025 Financial Results and Recent Operating Highlights - GlobeNewsWire
- 3 months ago - Clene to Present at the Emerging Growth Conference - GlobeNewsWire
- 3 months ago - Clene to Present at the Jones Healthcare and Technology Innovation Conference - GlobeNewsWire
- 4 months ago - Clene Reports Full Year 2024 Financial Results and Recent Operating Highlights - GlobeNewsWire
- 4 months ago - Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8® Treatment - GlobeNewsWire
- 4 months ago - Clene to Present at the 37TH Annual Roth Conference - GlobeNewsWire